Transaminase cii test wako
The Transaminase CII-test Wako is a laboratory equipment product designed for the quantitative determination of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels in human serum or plasma samples. It is a diagnostic tool used to assess liver function.
Lab products found in correlation
30 protocols using transaminase cii test wako
Plasma Transaminase Measurement in Mice
Hepatocyte Isolation and Characterization
Plasma Biochemical Analysis Protocol
Plasma alanine aminotransferase (ALT) and aspartate aminotransferase (AST) activities were measured using the Transaminase CII Test Wako (Wako Chemical) according to the manufacturer’s instructions and as previously described [20 (link), 21 (link)]. Concentrations of plasma creatinine and blood urea nitrogen (BUN) were measured using Creatinine Liquid Reagents Assay (DIAZYME, Poway, CA) and BUN Wako Test (Wako Chemical), respectively, according to the manufacturer’s instructions and as previously described [22 (link), 23 (link)]. For relative quantification, calibration curves were prepared using standard solutions.
Analysis of Blacklip Abalone Compounds
Serum Aminotransferase and Bilirubin Measurement
Liver Injury Biochemical Markers Assay
collected from heart with heparin-treated needle and syringe, and then centrifuged at ×
10,000 g for 10 min at 4°C to separate plasma fraction. Measurement of AST and ALT in
plasma sample was performed using Transaminase C-II-test WAKO (Wako Pure Chemical, Osaka,
Japan) according to the manufacturer’s instructions with brief modifications.
Con A-Induced Hepatitis Protocol
Transaminase Measurement for Liver Injury
Biomarker Assays for Metabolic Health
Effect of NEK6 Knockdown on Hepatic Disorder
Example 15
Fibrogenesis has been understood as an excessive wound healing process against disorder of a cell or tissue. Thus, suppression of disorder of a cell or tissue along with fibrogenesis has been considered to be effective for treatment of various fibrosis. Then, in order to investigate whether NEK6 knockdown would exhibit effect on hepatic disorder, measurement of hepatic disorder markers in CCl4 models was performed.
On day 13 after induction of pathology, blood draw was performed from tail vein using a plane capillary blood-sampling tube, and subjected to standing for 30 minutes or more. The post-standing blood was centrifuged to obtain serum. Serum glutamic pyruvic transaminase (GPT) and glutamic oxaloacetic transaminase (GOT) were measured using Transaminase CII-test Wako (Wako Pure Chemical Industries, Ltd.). Measurement method followed the instruction of the reagent.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!